Glycogen Storage Disease Type VI (Glycogenosis Type VI)

04/01/2008 - "Her disease remitted successfully after 4 doses of rituximab given at weekly intervals and she remained in continuous remission 6 months after therapy. "
03/01/2013 - "Therefore, we suggest that rituximab affected her disease rapidly and effectively. "
09/01/2007 - "Finally, 1 patient had worsening of her disease following rituximab. "
09/01/2005 - "Because of the refractory behavior of her disease, rituximab was administered. "
06/01/2005 - "Consequently, she was given Rituximab in courses of two to three doses, each dose 375 mg/m(2), at weekly intervals with remarkable stabilization of her disease for approximately 6 months."

07/01/1988 - "Cyclophosphamide was found to be highly effective in suppressing her disease over a period of six years."
06/01/1987 - "On three separate occasions her disease relapsed when cyclophosphamide therapy was discontinued. "
01/01/2013 - "The second patient was treated with rituximab and monthly cyclophosphamide infusions early in her disease course, and her vision improved dramatically. "
01/01/2013 - "She was treated with panretinal photocoagulation and steroid therapy and later in her disease course was treated with rituximab and cyclophosphamide. "
12/01/2003 - "Control of her disease required successive treatments of mycophenolate mofetil and cyclophosphamide, as well as corticosteroids. "

10/01/2007 - "She was admitted for the workup and management of her disease after she failed to respond to a course of oral steroids. "
05/01/2004 - "The patient was treated with steroid drugs to control the manifestations of her disease but exhibited early signs of femoral bone necrosis, which required discontinuation of the steroids. "
09/01/2001 - "A 38-year-old woman with limited cutaneous systemic sclerosis and pulmonary fibrosis developed diffuse alveolar hemorrhage during the course of her disease that responded well to steroids. "
12/01/2003 - "After partial improvement with low doses of oral steroids and azathioprine, her disease progressed to involve the oral cavity, trunk, hands, feet, and scalp. "
01/01/2010 - "Her disease activity was assessed as Stage IV and Class III by Steinbrocker's classification and resistant to steroids and methotrexate. "

07/01/2007 - "Treatment with methotrexate (MTX) resulted in a complete remission of her disease lasting for 54+ months. "
01/01/2011 - "She failed topical therapy and required systemic methotrexate to control her disease. "
01/01/2011 - "Because her disease was limited to the lungs, we successfully treated her with corticosteroids and methotrexate. "
01/01/2010 - "Her disease activity was assessed as Stage IV and Class III by Steinbrocker's classification and resistant to steroids and methotrexate. "
05/01/2009 - "Over a 4-year period her disease remained active during therapy with methotrexate and prednisone. "

10/01/2004 - "Her disease was successfully treated with prednisolone for almost two years. "
05/01/1995 - "She had received only low dose prednisolone (average 5-10 mg) as treatment for her disease, which appeared to be inactive at the time of her presentation with septicaemia. "
11/01/1993 - "We diagnosed her disease as Addison's disease caused by adrenal tuberculosis so we began to give prednisolone, 7.5 mg per day. "
01/01/1997 - "Efficacy of both oral prednisolone and of intravenous methylprednisolone pulse therapy for her disease was limited. "
11/01/1992 - "She had been on systemic steroids for 10 years since her last pregnancy in 1981 and required doses of 20-80 mg prednisolone daily to control her disease. "

12/01/2003 - "After partial improvement with low doses of oral steroids and azathioprine, her disease progressed to involve the oral cavity, trunk, hands, feet, and scalp. "
02/01/2008 - "She was treated with corticosteroids and azathioprine, but her disease progressed. "
04/01/2011 - "Her disease was resistant to corticosteroids, azathioprine, and mycophenolate mofetil. "
01/01/2009 - "Her disease was resistant to treatment with prednisone and azathioprine; however, infliximab effected good control, and she remains well on 8 weekly infusions 1 year later. "
10/01/2014 - "Azathioprine, hydroxychloroquine, rituximab, and moderate doses of prednisone were either unable to control her disease or led to unacceptable toxicity. "

11/01/2003 - "Under the diagnosis of RPLS, we successfully treated her disease using a trinitroglycerin as an antihypertensive, a hyperosmolar agent, methylprednisolone, and a free radical scavenger. "
01/01/1997 - "Efficacy of both oral prednisolone and of intravenous methylprednisolone pulse therapy for her disease was limited. "
08/01/1998 - "She was successfully treated with three pulses of methylprednisolone followed by two IVCY together with vasodilators for her disease activity of SLE including skin manifestation. "
12/01/2015 - "When the diagnosis of anti-NMDAR autoimmune encephalitis was finally confirmed by repeated immunological assays (specific immunoglobulin [Ig] G and IgM in her blood serum and cerebrospinal fluid), and a paraneoplastic process was ruled out, she was started on immunomodulating therapy (methylprednisolone, Ig, plasmapheresis, rituximab), which changed the course of her disease. "

01/01/2004 - "Her disease responded to treatment with topical tacrolimus ointment 0.1% within 3 months without any evidence for disease activity, except for slight residual scarring. "
03/01/2013 - "Add-on tocilizumab dramatically improved her disease state and enabled tapering of corticosteroid and tacrolimus. "
08/01/2010 - "Her disease subsequently recurred in the transplanted kidney despite standard immunosuppression with prednisone, tacrolimus, and mycophenolate mofetil. "

07/01/2009 - "Eventually she was treated successfully with infliximab, enabling her to undergo extensive surgery despite the fact that her disease was pathergic in onset."
11/01/2005 - "We report a case of a 54-year-old woman affected by SCPD who after failure of different therapies showed a dramatic but only temporary improvement of her disease during a cycle of therapy with infliximab. "
01/01/2009 - "Her disease was resistant to treatment with prednisone and azathioprine; however, infliximab effected good control, and she remains well on 8 weekly infusions 1 year later. "

11/01/1989 - "An adequately performed operation should render the patient free from her disease with a good cosmetic result. "
07/01/2001 - "The patient showed remarkable cosmetic improvement with no hypertrophic scarring and no reactivation of her disease. "

04/01/2008 - "Her disease responded well to chemotherapy but she later developed a fatal relapse in the CNS. "
01/01/2015 - "The patient was started on systemic chemotherapy, but her disease progressed with neurological involvement which responded to second-line therapy. "
01/01/2015 - "The patient, despite a transient initial response to chemotherapy with reduction of the bulky masses, rapidly progressed and died of her disease. "
05/01/2014 - "The patient was given one treatment of chemotherapy and was discharged to a hospice, where she died of her disease 2 weeks later. "
01/01/2014 - "Her disease condition did not abate with conservative treatment using antimicrobial chemotherapy. "

01/01/2011 - "Although she ultimately relapsed following her transplant, her disease has repeatedly returned into remission after donor lymphocyte infusion (DLI). "
07/01/2012 - "She had successful reversal of her disease, but experienced complications related to transplant. "
02/01/2010 - "Ten months after the onset of her disease, she received a simultaneous renal and adrenal gland transplant from her mother. "
04/01/2003 - "The patient had no pre-transplant history of extramedullary disease and no evidence of plasma cells in the peripheral blood at any time throughout the course of her disease. "
11/01/2002 - "She was then treated with an allogeneic peripheral blood stem-cell transplant that led to complete resolution of her disease. "

01/01/2015 - "After treatment with four courses of CHOP and later radiation to the floor of the mouth, her disease was in complete remission. "
04/01/1998 - "She subsequently had a successful pregnancy after treatment of her disease. "
07/01/2014 - "The FIGO stage of the vulvar cancer was stage IB (T1 N0 M0), but even with this low stage, the patient had recurrence 17 months after treatment and died of her disease 8 months later. "
10/01/1998 - "The woman was monitored closely throughout the course of her disease and radiogic, clinical, and serologic resolution was achieved after treatment with fluconazole. "
03/01/1992 - "The patient was not receiving non-steroidal anti-inflammatory drugs, and all laboratory and clinical manifestations of her disease rapidly resolved after treatment with prednisone. "

08/01/2006 - "She had been treated with tandem autologous stem cell transplantations and achieved complete remission before her disease relapsed. "
07/01/1998 - "We describe the case of a 39-year-old female who presented with stage IV-B large cell lymphoma 19 years after an initial diagnosis of PPBL; her disease was rapidly fatal despite intensive chemotherapy and blood stem cell transplantation. "
04/01/2015 - "•Vulvar yolk sac tumor (YST) is an exceptionally rare and aggressive extra-gonadal germ cell tumor, previously only described in 15 cases in the literature.•We present a unique case of vulvar YST diagnosed during pregnancy, treated with systemic chemotherapy, who subsequently recurred during a second pregnancy.•Despite salvage chemotherapy and autologous stem cell transplantation at recurrence, our patient succumbed to her disease, 31 months post diagnosis. "

10/01/1997 - "After chemotherapy, the girl had complete remission of her disease lasting for 18 months; however, the disease relapsed and autologous peripheral stem cell transplantation was performed. "